发明名称 |
beta ADRENERGIC RECEPTOR AGONIST |
摘要 |
PROBLEM TO BE SOLVED: To provideβ2 selective AR agonist having a sustained period of increased effect and/or longer action. SOLUTION: There are provided new multibinding compounds (medicines) which areβ2 adrenergic receptor agonists, partial agonists and pharmaceutical compositions containing the compounds. The multibinding compounds and the pharmaceutical compositions are useful in the treatment and prevention of respiratory diseases such as asthma, chronic obstructive pulmonary disease and chronic bronchitis. Further, the multibinding compounds and the pharmaceutical compositions are also useful in the treatment of nervous system injury and premature labor. COPYRIGHT: (C)2010,JPO&INPIT
|
申请公布号 |
JP2010132692(A) |
申请公布日期 |
2010.06.17 |
申请号 |
JP20100036664 |
申请日期 |
2010.02.22 |
申请人 |
THERAVANCE INC |
发明人 |
MORAN EDMUND J;GRIFFIN JOHN H;CHOI SEOK-KI |
分类号 |
A61P3/04;C07C215/14;A61K;A61K31/135;A61K31/137;A61K31/138;A61K31/165;A61K31/167;A61K31/403;A61K31/404;A61K31/4164;A61K31/4706;A61K38/00;A61K39/00;A61K39/395;A61K39/44;A61K45/00;A61K45/06;A61K51/00;A61P;A61P1/00;A61P3/10;A61P11/00;A61P11/06;A61P11/08;A61P15/06;A61P25/00;A61P43/00;C07B61/00;C07C;C07C213/00;C07C215/16;C07C215/60;C07C215/68;C07C217/10;C07C217/18;C07C233/43;G01N33/53;G01N33/543;G01N33/566 |
主分类号 |
A61P3/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|